Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Healthcare US CUPR

3.97USD
1.56(64.73%)

Last update at 2026-06-12T20:29:00Z

Day Range

3.218.23
LowHigh

52 Week Range

0.289.50
LowHigh

Fundamentals

  • Previous Close 2.41
  • Market Cap7.17M
  • Volume82999554
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.81024M
  • Revenue TTM0.03M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM -0.02100M
  • Diluted EPS TTM-0.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -1.50860M -1.08577M -1.08717M -0.51969M
Minority interest - - - -
Net income -1.56054M -1.11956M -1.09452M -0.51969M
Selling general administrative 1.26M 0.83M 0.79M 0.25M
Selling and marketing expenses 0.00650M 0.00674M 0.04M 0.00009M
Gross profit -0.00302M 0.04M 0.02M 0.02M
Reconciled depreciation 0.04M 0.04M 0.03M 0.03M
Ebit -1.47139M -1.02918M -1.08515M -0.51690M
Ebitda -1.42921M -0.99412M -1.05607M -0.48945M
Depreciation and amortization 0.04M 0.04M 0.03M 0.03M
Non operating income net other - - - -
Operating income -1.64526M -1.06833M -1.17579M -0.55275M
Other operating expenses 1.69M 1.17M 1.23M 0.61M
Interest expense 0.04M 0.06M 0.00202M 0.00278M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - - - -
Net interest income -0.03721M -0.05659M -0.00202M -0.00278M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.05M 0.03M 0.00734M -
Total revenue 0.05M 0.10M 0.06M 0.06M
Total operating expenses 1.64M 1.10M 1.20M 0.58M
Cost of revenue 0.05M 0.06M 0.04M 0.04M
Total other income expense net 0.14M -0.01744M 0.09M 0.03M
Discontinued operations - - - -
Net income from continuing ops -1.56054M -1.11956M -1.09452M -0.51969M
Net income applicable to common shares - - - -
Preferred stock and other adjustments - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1.75M 1.59M 1.44M 0.95M
Intangible assets - - - -
Earning assets - - - -
Other current assets 1.42M 1.18M 0.26M 0.02M
Total liab 6.20M 4.48M 3.21M 1.64M
Total stockholder equity -4.45972M -2.89728M -1.77830M -0.68352M
Deferred long term liab - - - -
Other current liab 5.95M 4.36M 3.03M 1.47M
Common stock 0.02M 0.02M 0.02M 0.02M
Capital stock 0.02M 0.02M 0.02M 0.02M
Retained earnings -4.56105M -3.00052M -1.88096M -0.78645M
Other liab - - - -
Good will - - - -
Other assets - - - -
Cash 0.12M 0.04M 0.56M 0.77M
Cash and equivalents - - - -
Total current liabilities 6.04M 4.43M 3.09M 1.51M
Current deferred revenue - - - -
Net debt 0.14M 0.09M -0.38094M -0.59726M
Short term debt 0.09M 0.06M 0.06M 0.04M
Short long term debt 0.06M 0.02M 0.02M 0.02M
Short long term debt total 0.25M 0.12M 0.18M 0.17M
Other stockholder equity 0.08M 0.08M 0.08M 0.08M
Property plant equipment - - - -
Total current assets 1.66M 1.44M 1.27M 0.81M
Long term investments 0.00000M 0.00000M 0.00789M 0.00000M
Net tangible assets - - - -
Short term investments - - - -
Net receivables 0.12M 0.21M 0.44M 0.02M
Long term debt 0.16M 0.02M 0.04M 0.06M
Inventory 0.00173M 0.00766M 0.00650M 0.00000M
Accounts payable - 0.00000M 0.00000M 0.00022M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -0.00159M 0.00031M -0.00026M -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 0.09M 0.15M 0.17M 0.14M
Capital lease obligations 0.04M 0.08M 0.12M 0.09M
Long term debt total - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.02188M -0.06798M -0.03128M -0.00286M
Change to liabilities - - - -
Total cashflows from investing activities -0.02188M -0.06798M -0.03128M -0.00286M
Net borrowings 0.18M -0.02057M -0.01946M 0.08M
Total cash from financing activities 1.34M 1.08M 1.68M 0.99M
Change to operating activities - - - -
Net income -1.56054M -1.11956M -1.09452M -0.51969M
Change in cash 0.08M -0.52931M -0.20272M 0.77M
Begin period cash flow 0.04M 0.56M 0.77M 0.00062M
End period cash flow 0.12M 0.04M 0.56M 0.77M
Total cash from operating activities -1.23598M -1.54278M -1.84967M -0.22186M
Issuance of capital stock - - - -
Depreciation 0.04M 0.04M 0.03M 0.03M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory 0.00000M -0.00116M -0.00650M 0.00000M
Change to account receivables 0.02M -0.03502M -0.03825M -0.01880M
Sale purchase of stock - - - -
Other cashflows from financing activities 1.16M 1.10M 1.70M 0.91M
Change to netincome - - - -
Capital expenditures 0.02M 0.07M 0.02M 0.00286M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 0.23M -0.52307M -0.80722M 0.27M
Stock based compensation - - - -
Other non cash items 0.05M 0.06M 0.02M 0.00458M
Free cash flow -1.25787M -1.61075M -1.86572M -0.22472M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares		 1.56 64.73% 3.97 - - 236.27 1.19 171.67
ISRG
Intuitive Surgical Inc		 -1.84 0.45% 411.06 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 199.27 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 0.49 0.46% 106.20 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -1.11 0.75% 146.24 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Blk 1090, Singapore, Singapore, 169201

Key Executives

Name Title Year Born
Mr. Yong Qi Quek CEO & Director 1995
Mr. Tat Jing Chan Chief Financial Officer 1992
Dr. Ronald Sherman Medical & Scientific Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.